Anti-TNF therapy in the injured spinal cord - ScienceDirect
IJMS | Free Full-Text | A New Venue of TNF Targeting
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement | European Respiratory Society
Article
Schematic of TNF inhibitors and their mode of action. Receptor (i.e.... | Download Scientific Diagram
Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF | Annals of the Rheumatic Diseases
Internet Scientific Publications
TNF-alpha Inhibitors - MSK - Medbullets Step 1
TNF-a inhibitors Simplified for the USMLE and COMLEX - YouTube
Striking a new path – extending the diagnostic portfolio by test systems for therapeutic drug monitoring - EUROIMMUNBlog
Frontiers | Targeting TNF-α for COVID-19: Recent Advanced and Controversies
Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls | Immunotherapy
Classes of Biologics for the Treatment of IBD - ALPCO
Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases. | Semantic Scholar
PDF] Inhibitors of tumor necrosis factor-a and mechanisms of their action | Semantic Scholar
Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases
Etanercept - YouTube
Brain TACE (Tumor Necrosis Factor-α–Converting Enzyme) Contributes to Sympathetic Excitation in Heart Failure Rats | Hypertension
Frontiers | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Frontiers | Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology
Structure (A); and mechanisms of action (B) of anti-TNF biologics. All... | Download Scientific Diagram
Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor | Cellular & Molecular Immunology
Frontiers | Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
Molecular mechanisms of action of anti-TNF-α agents – Comparison among therapeutic TNF-α antagonists - ScienceDirect
The Role of Infliximab Biosimilar CT-P13 in Inflammatory Bowel Disease